OBJECTIVE: To assess the relationship between the development of transient post-operative atrial fibrillation (TPOAF) following coronary artery bypass graft (CABG) surgery and risk of long-term mortality. BACKGROUND: Atrial fibrillation (AF) following CABG is common and associated with increased morbidity and mortality in the perioperative period. However the impact of TPOAF and its management on long-term morbidity and mortality in patients undergoing first time, isolated CABG surgery remains unclear. METHODS: The Cleveland Clinic Cardiovascular Information Registry was used to identify 5,205 consecutive patients who underwent CABG between January 1993 and December 2005. Patients with TPOAF (n=1,490) were compared to those without post-operative AF (n=3,645) for the endpoints of death, myocardial infarction (MI), or stroke at 1 year. RESULTS: Overall rates of 1-year mortality, MI and stroke were 3.7%, 0.8%, and 2.6%, respectively. Patients with TPOAF had an increased risk of death at 1 year as compared to patients without POAF (6.4% vs. 2.7%; P<0.001), but there was not an increased risk of stroke or MI. Multivariate analysis identified TPOAF as an independent predictor of death at 1 year (HR 1.89, 95% CI, 1.42-2.53; P<0.001). After propensity matching, patients who developed TPOAF experienced a significantly increased risk of death compared with those without TPOAF (HR 1.96, 95% CI, 1.34-2.86; P<0.001). CONCLUSIONS: In patients undergoing first time, isolated CABG, the presence of TPOAF identifies a subgroup of patients at increased risk for all-cause mortality. Future prospective studies to determine potential beneficial interventions in this large population are warranted.
OBJECTIVE: To assess the relationship between the development of transient post-operative atrial fibrillation (TPOAF) following coronary artery bypass graft (CABG) surgery and risk of long-term mortality. BACKGROUND:Atrial fibrillation (AF) following CABG is common and associated with increased morbidity and mortality in the perioperative period. However the impact of TPOAF and its management on long-term morbidity and mortality in patients undergoing first time, isolated CABG surgery remains unclear. METHODS: The Cleveland Clinic Cardiovascular Information Registry was used to identify 5,205 consecutive patients who underwent CABG between January 1993 and December 2005. Patients with TPOAF (n=1,490) were compared to those without post-operative AF (n=3,645) for the endpoints of death, myocardial infarction (MI), or stroke at 1 year. RESULTS: Overall rates of 1-year mortality, MI and stroke were 3.7%, 0.8%, and 2.6%, respectively. Patients with TPOAF had an increased risk of death at 1 year as compared to patients without POAF (6.4% vs. 2.7%; P<0.001), but there was not an increased risk of stroke or MI. Multivariate analysis identified TPOAF as an independent predictor of death at 1 year (HR 1.89, 95% CI, 1.42-2.53; P<0.001). After propensity matching, patients who developed TPOAF experienced a significantly increased risk of death compared with those without TPOAF (HR 1.96, 95% CI, 1.34-2.86; P<0.001). CONCLUSIONS: In patients undergoing first time, isolated CABG, the presence of TPOAF identifies a subgroup of patients at increased risk for all-cause mortality. Future prospective studies to determine potential beneficial interventions in this large population are warranted.
Authors: T Bruce Ferguson; Bradley G Hammill; Eric D Peterson; Elizabeth R DeLong; Frederick L Grover Journal: Ann Thorac Surg Date: 2002-02 Impact factor: 4.330
Authors: Arnljot Tveit; Morten Grundtvig; Torstein Gundersen; Paul Vanberg; Anne Grete Semb; Even Holt; Lars Gullestad Journal: Am J Cardiol Date: 2004-03-15 Impact factor: 2.778
Authors: Joseph E Ebinger; Brandon R Porten; Craig E Strauss; Ross F Garberich; Christopher Han; Sharon K Wahl; Benjamin C Sun; Raed H Abdelhadi; Timothy D Henry Journal: Circ Cardiovasc Qual Outcomes Date: 2016-08-23
Authors: Junaid A B Zaman; Leanne Harling; Hutan Ashrafian; Ara Darzi; Nigel Gooderham; Thanos Athanasiou; Nicholas S Peters Journal: Int J Cardiol Date: 2016-06-28 Impact factor: 4.164
Authors: Giovanni Filardo; Benjamin D Pollock; Briget da Graca; Danielle M Sass; Teresa K Phan; Debbie E Montenegro; Gorav Ailawadi; Vinod H Thourani; Ralph J Damiano Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2020-12-10